DULOXETINE ZENTIVA 60 mg, gastro-resistant capsule 28 capsules
Active ingredients: Duloxetine hydrochloride, DULOXÉTINE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Gastro-resistant capsule28 capsulesorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- DULOXETINE ZENTIVA 60 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 28 gélule(s)
- Marketing authorisation holder
- ZENTIVA (REPUBLIQUE TCHEQUE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Jun 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60287277CIP73021821CIP133400930218211Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DULOXÉTINEgélule | 60 mg · une gélule | FT |
| CHLORHYDRATE DE DULOXÉTINEgélule | 67,35 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.